Entries by Administrator

, , ,

The FDA weighs in on market research and drug developers are listening – especially to the underserved

Thanks to the meteoric rise of digital health, the role of data and analytics has also become central across the drug development life cycle, impacting every touch point from pipeline research and development to clinical trial design and implementation. A critical area that has fallen short, however, is applying a commensurate level of enthusiasm and expense for market research in the early phase as that afforded to downstream commercialization efforts. Compounding this challenge is the continued marginalization of disenfranchised communities. 

, , ,

Small town, big impact: Smart storytelling in rare disease

More than 90 percent of rare diseases have no FDA-approved treatment, and it can take seven to eight years just to get diagnosed. It’s a zero-sum game for marketers because we’re walking onto an empty field full of people desperate for someone to join their team. We have the opportunity to make a substantial impact in the small towns of rare disease.

, ,

Is pharma ready for the metaverse?

Once upon a time, medical communications depended on printed materials and face-to-face communications – words and pictures on a page, or live meetings. Life was simple. But then, something called the internet interrupted this joyful prehistoric reverie. Another inflection point may nearly be upon us. You may have heard of it? It’s called the metaverse.

, ,

A new era of leadership convenes for HBA’s annual Woman of the Year event in New York

Mindful that the world at large and the industry workplace has been forever changed after the last 24 months, the HBA leveraged this annual event to recognize how industry champions have demonstrated the acumen, attributes, and values that are critical, timely, and relevant to successfully lead the greater healthcare and life sciences communities.